Anzeige
Mehr »
Login
Mittwoch, 12.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
KI-Bohrstrategie gestartet: KI trifft Kupfer - Dieses Unternehmen plant nächste Explorationsrunde
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
107 Leser
Artikel bewerten:
(0)

ArisGlobal Signs EU AI Pact In Latest Commitment to Ethical AI Practices, Essential For Societal Benefits Including Enhanced Patient Safety

Finanznachrichten News

The EU AI Pact supports organizations in preparing for the EU AI Act, the world's first comprehensive AI law. Joining the AI Pact reinforces ArisGlobal's belief in a future underpinned by responsible AI.

BOSTON, Feb. 12, 2025 /PRNewswire/ -- ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced its official signing of the European Union's AI Pact agreement. The public pledge promotes responsible and ethical AI development and deployment, underpinning AI's "bigger picture": its benefits to society.

ArisGlobal Logo

The AI Pact is a voluntary framework created by the European Commission to help stakeholders prepare for the implementation of the EU AI Act. It is the first comprehensive regulation on AI by a major regulator globally.

By making this pledge, ArisGlobal is publicly confirming its commitment to uphold the highest standards and best practices related to AI governance, ethics, and responsibility. This will ensure that its life sciences clients can trust the benefits delivered by the technology, for instance in the form of new or honed patient safety insights.

ArisGlobal has signed the Pact as a demonstration of its commitment to customers of its LifeSphere Regulatory and Safety platform, powered by its advanced cognitive computing engine, NavaX.

By participating in the initiative, ArisGlobal is committing to:

  • AI governance strategy to foster the uptake of AI in the organization and work towards future compliance with the AI Act;
  • High-risk AI systems mapping: identifying AI systems likely to be categorized as high-risk under the AI Act; and
  • Promoting AI literacy and awareness among staff, ensuring ethical and responsible AI development.

Jason Bryant, ArisGlobal's Vice President of Product Management for AI & Data, said, "At ArisGlobal, we believe that AI should benefit society, which isn't possible without ethical AI practices. We take responsible AI very seriously. That is both via our leadership position in the industry, and as we apply the technology to deliver advanced insight - allowing our customers to make better decisions that feed into patient safety. Joining the AI Pact reinforces our commitment, and our belief in a future underpinned by responsible AI."

He added, "Our progress will be as visible as our commitment. We will report on our performance against our core promises, as well as additional approaches we'll be taking to drive best-of-breed industry behavior."

About ArisGlobal

ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn or visit arisglobal.com.

Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/arisglobal-signs-eu-ai-pact-in-latest-commitment-to-ethical-ai-practices-essential-for-societal-benefits-including-enhanced-patient-safety-302374655.html

© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.